Definitive Healthcare Financials - Benzinga

Definitive Healthcare Corp

DHNASDAQ

Trade with Public

Trade with Public

$0.7141

-0.0134-1.84%

At close: Aug 21, 5:00 PM EST

$0.7141

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Definitive Healthcare Financials

Definitive Healthcare (DH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est

Definitive Healthcare (NASDAQ:DH) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 analyst estimate. Narrows FY2026 sales outlook from $220.000 million-$226.000 million to $220.000

Benzinga Newsdesk

PRO
Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est

Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.04-$0.05 vs $0.04 analyst estimate. sees sales of $54.000 million-$55.000 million vs $55.542 million analyst estimate.

Benzinga Newsdesk

PRO
Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 28.57 percent decrease over earnings of $0.07 per share from

Benzinga Newsdesk

PRO
Definitive Healthcare Sees Q2 Adj EPS $0.03-$0.04 vs $0.04 Est; Sees Sales $55.000M-$56.000M vs $55.740M Est

Benzinga Newsdesk

PRO
Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.14-$0.17 to $0.16-$0.19 vs $0.17 Est; Affirms FY2026 Sales Guidance of $220.000M-$226.000M vs $223.509M Est

Benzinga Newsdesk

PRO
Definitive Healthcare Q1 Adj. EPS $0.06 Beats $0.03 Estimate, Sales $55.929M Beat $55.405M Estimate

Benzinga Newsdesk